M2 macrophage-mediated tigecycline nanoparticles for combating CRKP pneumonia via antibacterial and immunomodulatory therapy

Journal of Controlled Release 2026

View at publisher

Authors: Wu Cheng, Ling Wu, Yun Liao, Wenjie Zhang, Xiujuan Han, Zongguang Tai, Quangang Zhu, Zhongjian Chen, J. M. Tian, Nan Ding, Zhuo Wang

DOI: 10.1016/j.jconrel.2026.114810

Cited by: 2

References: 47

Fields of Study & Subjects

Immune cells in cancer Nanoplatforms for cancer theranostics Immune Response and Inflammation

References 47